Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Alzheimer's Disease
95%
Alzheime's Disease
95%
Mild Cognitive Impairment
48%
Dementia
41%
Frontotemporal Dementia
27%
Atherosclerotic Risk Factors
26%
Mayo Clinic Study of Aging
25%
Dementia with Lewy Bodies
21%
Neurodegeneration
19%
Cognitive Impairment
19%
Frontotemporal Lobar Degeneration
19%
Cognitive Decline
18%
Apolipoprotein E4 (APOE4)
15%
Cognitively Normal
14%
95% Confidence Interval
12%
Older Adults
12%
Cognitively Unimpaired
12%
Later Life
11%
Alzheimer's Disease Dementia
11%
TAR DNA-binding Protein 43 (TDP-43)
11%
Imaging Biomarkers
11%
Tau PET
10%
Amyloid PET
10%
White Matter Hyperintensities
10%
Atrophy
10%
Neuropathology
10%
Cognitive Dementia
10%
Cognitive Function
9%
Population-based Study
9%
Incident Dementia
9%
Clinical Trials
9%
Amnestic Mild Cognitive Impairment (aMCI)
9%
Dementia Risk
9%
Cardiac Magnetic Resonance Imaging (cMRI)
8%
Hazard Ratio
8%
Standardized Uptake Value
8%
Cognitive Change
8%
Pittsburgh Compound B
8%
Hippocampal Volume
8%
C9orf72
7%
Alzheimer's Disease Pathology
7%
Odds Ratio
7%
Neurocognitive
7%
Alzheimer
7%
Aging
7%
Cortical Thickness
7%
Amyloid Positron Emission Tomography
7%
Brain Atrophy
6%
Temporal Lobe
6%
Cerebrospinal Fluid
6%
Neuroscience
Alzheimer's Disease
100%
Amyloid Protein
44%
Mild Cognitive Impairment
40%
Biological Marker
35%
Magnetic Resonance Imaging
33%
Positron Emission Tomography
22%
Dementia with Lewy Bodies
18%
Positron Emission Tomography
18%
Neurodegeneration
17%
Cognitive Disorders
16%
Frontotemporal Dementia
16%
Cognitive Decline
15%
Blood Plasma
14%
Genetics
13%
Risk Factor
10%
Frontal Variant Frontotemporal Dementia
9%
Cerebrovascular Disease
9%
Apolipoprotein E
8%
Older Adults
8%
Temporal Lobe
8%
Cognitive Function
7%
Fluorine-18
6%
Gray Matter
6%
Cerebrovascular Accident
6%
Cortical Thickness
5%
Neuropsychiatric Symptom
5%
Medicine and Dentistry
Alzheimer's Disease
50%
Amyloid Protein
30%
Magnetic Resonance Imaging
20%
Tau
18%
Mild Cognitive Impairment
18%
Polyethylene Terephthalate
15%
Biological Marker
15%
Atherosclerosis
15%
Positron Emission Tomography
13%
Diffuse Lewy Body Disease
13%
Frontotemporal Lobar Degeneration
11%
Cognitive Decline
9%
Cognitive Defect
8%
Neurodegeneration
8%
Pittsburgh Compound B
7%
Diseases
7%
Hazard Ratio
6%
Cognition
5%
Clinical Trial
5%